MEDAG

MEDAG

Target · Adipogenesis regulator

MEDAG Mesenteric oestrogen-dependent adipogenesis protein

MEDAG (mesenteric oestrogen dependent adipogenesis, also known as MEDA-4, AWMS3, FLJ14834 and C13orf33) is a cytoplasmic protein linked to adipocyte biology. It is involved in processes that promote adipocyte differentiation, lipid accumulation and glucose uptake in mature adipocytes. Browse Assay Genie's current range of MEDAG research reagents below, or read on for the biology behind the target.

Cytoplasmic proteinPromotes adipocyte differentiationLipid accumulation and glucose uptake
303 aa
Protein length
~34 kDa
Molecular weight
13q12.3
Gene locus
Adipogenesis
Functional area
Target information

What is MEDAG (mesenteric oestrogen dependent adipogenesis)?

MEDAG is involved in processes that promote adipocyte differentiation, lipid accumulation and glucose uptake in mature adipocytes. The NCBI Gene summary describes it as predicted to be involved in positive regulation of fat cell differentiation, and places the protein in the cytoplasm. Together, these annotations make the MEDAG protein a point of interest for researchers studying how fat cells develop and how mature adipocytes handle lipid and glucose.

The MEDAG gene encodes the mesenteric oestrogen-dependent adipogenesis protein, a 303-amino-acid polypeptide listed in UniProt under Q5VYS4. The gene is not assigned to an HGNC gene group, and the source annotations do not define a protein family or an enzymatic activity. The available functional description is therefore framed in terms of cellular processes rather than a defined biochemical mechanism. Mouse has an orthologous gene, Medag, which is relevant to anyone planning comparative or model-organism work.

The name reflects the origin of the gene's description. HGNC records the approved name as mesenteric oestrogen dependent adipogenesis, and the previous names as chromosome 13 open reading frame 33 and mesenteric oestrogen-dependent adipogenesis. Earlier symbols and aliases include C13orf33, FLJ14834, AWMS3 and MEDA-4, all of which may appear in older literature and database records. Searching under every alias helps when reviewing earlier publications on MEDAG.

Adipocyte differentiation

MEDAG is involved in processes that promote adipocyte differentiation, making it relevant to studies of how precursor cells become fat cells.

Lipid accumulation

The protein is implicated in lipid accumulation in mature adipocytes, a feature of interest in adipose tissue biology.

Glucose uptake in adipocytes

MEDAG is associated with processes promoting glucose uptake in mature adipocytes, linking it to research on adipocyte metabolic function.

Cytoplasmic protein studies

MEDAG is located in the cytoplasm, so its role can be examined in intracellular compartments of differentiating and mature fat cells.

Background

MEDAG frequently asked questions

What does MEDAG do?

MEDAG is involved in processes that promote adipocyte differentiation, lipid accumulation and glucose uptake in mature adipocytes. NCBI Gene describes it as predicted to be involved in positive regulation of fat cell differentiation. The protein is located in the cytoplasm.

What other names does MEDAG go by?

MEDAG stands for mesenteric oestrogen dependent adipogenesis. Aliases and earlier symbols include FLJ14834, AWMS3, MEDA-4 and C13orf33. Previous names recorded by HGNC are chromosome 13 open reading frame 33 and mesenteric oestrogen-dependent adipogenesis.

Does MEDAG have orthologs in other species?

The mouse ortholog is Medag. No rat ortholog is given in the data supplied here. When working with non-human samples, check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other adipogenesis, lipid metabolism and adipocyte markers with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q5VYS4; product specifications from Assay Genie datasheets.

MEDAG Product listing